Nutraceuticals
Tap into PIPA’s unified knowledge graph purpose-built on Nutrition, Food and Biology data to design advanced nutraceuticals that elevate health and promote wellbeing.
Streamline ingredient research and formulation through AI to identify novel bioactives and optimal pairings. Create effective, safe and science-backed dietary supplements that address consumer needs and preferences.
AI for Nutraceuticals R&D
A FASTER WAY TO DISCOVER NOVEL BIOACTIVES
We’ve only discovered and characterized a fraction of natural compounds and their bioactivity. PIPA’s unified knowledge graph, integrating millions of scientific articles and dozens of knowledge bases and omics data, predicts novel health effects for ingredients giving you a headstart in designing unique, targeted formulations. PIPA has the technological capability to discover bioactive ingredients at 100x accuracy and 12x faster than traditional assay-driven methods.
OPTIMIZE NUTRACEUTICAL FORMULATIONS
Identifying the right ingredients and most efficient blends for dietary supplements is a painstakingly long process of trial and error. By harnessing data science and AI, you can identify promising bioactives and other compounds from an exhaustive pool of well-known and unsuspected ingredients from plants and other food sources. In silico discovery informs downstream experiments, saving you time and resources as you only test the most promising candidates recommended by AI.
SCIENCE-BACKED FOOD SUPPLEMENTS
Consumers have high expectations from dietary supplements. Purity, efficacy and safety are non-negotiable purchase criteria. The PIPA knowledge graph helps you find scientific evidence on the function, pathways and synergistic effect of molecules. An otherwise long and tedious process is accelerated by harnessing a machine-read corpus of vetted scientific knowledge so you can design hard-to-copy supplements; from multivitamins and probiotics to herbal blends.
You're in good hands
Case studies
BIOACTIVE COMPOUND DISCOVERY FOR ORAL HEALTH
PIPA and partners used LEAP™ to discover novel bioactive compounds in foods ingredients that could potentially promote oral health through microbiota or host interactions. The AI-powered discoveries informed downstream screenings achieving multifold increase in bioactivity hit rates when compared to assay-driven methods.
BIOACTIVE DISCOVERY IN UPCYCLED INGREDIENT
Evergrain by AbinBev aimed to explore new potential health benefits associated with a specific plant-based protein isolate. PIPA employed LEAP to investigate the possible health effects of the isolate’s polyphenolic and peptidomic content. This was achieved by compiling scientific evidence that showcases its potential impact on human health.
Through our engagement Evergrain obtained valuable scientific insights within a matter of months, a feat that would typically take up to three years through conventional discovery methods. Building upon the initial findings, our client will delve deeper into exploring the over 600 identified health associations and more than 200 bioactive peptides.
This exploration will support the strategic positioning of their core ingredient in existing and emerging markets.
BIOACTIVE MOLECULE DISCOVERY FOR HEALTH AGING
PIPA leveraged its AI app LEAP™ and in-house pipelines to identify novel, plant-derived bioactives with senolytic and or senomorphic activity. In addition to the candidate targets, PIPA recommended key plant sources for sourcing the potentially bioactive molecules. Our partner leveraged our in silico predictions to inform downstream analysis and validation.
Let’s advance scientific discovery together
Unlock a faster path to innovation by leveraging our AI apps and tapping into the expertise of our top-class talent.
